Xylem Inc. 's ( XYL - Free Report ) third-quarter 2022 adjusted earnings (excluding 72 cents from non-recurring items) of 79 cents per share, surpassed the Zacks Consensus Estimate of 66 cents. The bottom line increased 25.4% year over year. Xylem's revenues of $1,380 million also outperformed the Zacks Consensus Estimate of $1,330 million and inched up approximately 9.1% year over year. Organic sales in the quarter rose 16%. Orders in the reported quarter decreased 7% year over year to $1,419 million. Organically, orders decreased by 1% owing to currency differences.